Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) — Net Asset Quality Index
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a Net Asset Quality Index of 50.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs2.94 Billion minus total liabilities of Rs1.45 Billion yields net assets of Rs1.49 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Aarey Drugs & Pharmaceuticals Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Aarey Drugs & Pharmaceuticals Limited Net Asset Quality Index Over Time (2009–2025)
This chart shows how Aarey Drugs & Pharmaceuticals Limited's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of September 2025, the index stands at 50.6%, representing net assets of Rs1.49 Billion against total assets of Rs2.94 Billion INR. See how liquid is Aarey Drugs & Pharmaceuticals Limited's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Aarey Drugs & Pharmaceuticals Limited (2009–2025)
The table below presents the year-by-year Net Asset Quality Index for Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see AAREYDRUGS stock market capitalisation.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 58.1% | Rs1.38 Billion | Rs2.38 Billion | Rs997.86 Million | ▲ +14.3 pp |
| 2024 | 43.8% | Rs1.33 Billion | Rs3.03 Billion | Rs1.71 Billion | ▲ +3.5 pp |
| 2023 | 40.3% | Rs1.17 Billion | Rs2.91 Billion | Rs1.74 Billion | ▼ -6.0 pp |
| 2022 | 46.4% | Rs1.14 Billion | Rs2.45 Billion | Rs1.32 Billion | ▲ +3.9 pp |
| 2021 | 42.4% | Rs988.60 Million | Rs2.33 Billion | Rs1.34 Billion | ▼ -5.2 pp |
| 2020 | 47.6% | Rs923.46 Million | Rs1.94 Billion | Rs1.02 Billion | ▼ -11.8 pp |
| 2019 | 59.4% | Rs865.53 Million | Rs1.46 Billion | Rs591.63 Million | ▲ +12.1 pp |
| 2018 | 47.3% | Rs802.45 Million | Rs1.70 Billion | Rs895.47 Million | ▲ +12.1 pp |
| 2017 | 35.2% | Rs503.60 Million | Rs1.43 Billion | Rs929.07 Million | ▲ +5.8 pp |
| 2016 | 29.4% | Rs366.97 Million | Rs1.25 Billion | Rs883.00 Million | ▼ -1.4 pp |
| 2015 | 30.8% | Rs354.09 Million | Rs1.15 Billion | Rs795.40 Million | ▼ -1.5 pp |
| 2014 | 32.3% | Rs345.21 Million | Rs1.07 Billion | Rs723.68 Million | ▲ +1.0 pp |
| 2013 | 31.2% | Rs334.70 Million | Rs1.07 Billion | Rs736.46 Million | ▼ -6.5 pp |
| 2012 | 37.8% | Rs328.12 Million | Rs868.36 Million | Rs540.24 Million | ▼ -13.6 pp |
| 2011 | 51.3% | Rs219.05 Million | Rs426.64 Million | Rs207.59 Million | ▲ +16.1 pp |
| 2010 | 35.3% | Rs92.08 Million | Rs261.20 Million | Rs169.12 Million | ▼ -19.3 pp |
| 2009 | 54.5% | Rs83.97 Million | Rs154.04 Million | Rs70.06 Million | — |